CINCINNATI--(BUSINESS WIRE)--Mar. 18, 2014--
Chemed Corporation (NYSE: CHE) (“Chemed” or the “Company”) today
announced the conversion rate on its 1.875% convertible senior notes due
May 15, 2014, (the “notes”) has been adjusted to 12.7603 shares of
Chemed's capital stock per $1,000 principal amount of the notes. The
adjusted conversion rate is equivalent to an adjusted conversion price
of approximately $78.37 per share and became effective on February 27,
2014. The notes mature on May 15, 2014, and are convertible in
accordance with their terms prior to the close of business on May 12,
2014, the third business day preceding the maturity date. For all
conversions prior to maturity, the consideration payable upon conversion
will be based on the volume-weighted average price of Chemed’s capital
stock over a 40 trading day measurement period, which began on March 17,
2014, and is expected to end on May 12, 2014.
Listed on the New York Stock Exchange and headquartered in Cincinnati,
Ohio, Chemed Corporation (www.chemed.com)
operates two wholly owned subsidiaries: VITAS Healthcare and
Roto-Rooter. VITAS is the nation's largest provider of end-of-life
hospice care and Roto-Rooter is the nation’s leading provider of
plumbing and drain cleaning services.
Statements in this press release or in other Chemed communications may
relate to future events or Chemed's future performance. Such statements
are forward-looking statements and are based on present information
Chemed has related to its existing business circumstances. Investors are
cautioned that such forward-looking statements are subject to inherent
risk that actual results may differ materially from such forward-looking
statements. Further, investors are cautioned that Chemed does not assume
any obligation to update forward-looking statements based on
unanticipated events or changed expectations.
Source: Chemed Corporation
Chemed Corporation
David P. Williams, 513-762-6901